Literature DB >> 18214973

Current topics in computer-aided drug design.

Carlton A Taft1, Vinicius Barreto Da Silva, Carlos Henrique Tomich De Paula Da Silva.   

Abstract

The addition of computer-aided drug design (CADD) technologies to the research and drug discovery approaches could lead to a reduction of up to 50% in the cost of drug design. Designing a drug is the process of finding or creating a molecule which has a specific activity on a biological organism. Development and drug discovery is a time-consuming, expensive, and interdisciplinary process whereas scientific advancements during the past two decades have altered the way pharmaceutical research produces new bioactive molecules. Advances in computational techniques and hardware solutions have enabled in silico methods to speed up lead optimization and identification. We will review current topics in computer-aided molecular design underscoring some of the most recent approaches and interdisciplinary processes. We will discuss some of the most efficient pathways and design. (Copyright) 2008 Wiley-Liss, Inc.

Mesh:

Year:  2008        PMID: 18214973     DOI: 10.1002/jps.21293

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  23 in total

Review 1.  Biomolecular simulation and modelling: status, progress and prospects.

Authors:  Marc W van der Kamp; Katherine E Shaw; Christopher J Woods; Adrian J Mulholland
Journal:  J R Soc Interface       Date:  2008-12-06       Impact factor: 4.118

2.  Studies of H4R antagonists using 3D-QSAR, molecular docking and molecular dynamics.

Authors:  Jing Liu; Yan Li; Hui-Xiao Zhang; Shu-Wei Zhang; Ling Yang
Journal:  J Mol Model       Date:  2011-06-07       Impact factor: 1.810

3.  Computer-aided molecular design of 1H-imidazole-2,4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme.

Authors:  Legesse Adane; Prasad V Bharatam
Journal:  J Mol Model       Date:  2010-06-05       Impact factor: 1.810

Review 4.  Molecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospects.

Authors:  Elisa Fadda; Robert J Woods
Journal:  Drug Discov Today       Date:  2010-06-08       Impact factor: 7.851

5.  Structure-activity relationships of thiostrepton derivatives: implications for rational drug design.

Authors:  Antje Wolf; Sebastian Schoof; Sascha Baumann; Hans-Dieter Arndt; Karl N Kirschner
Journal:  J Comput Aided Mol Des       Date:  2014-10-04       Impact factor: 3.686

6.  BSP-SLIM: a blind low-resolution ligand-protein docking approach using predicted protein structures.

Authors:  Hui Sun Lee; Yang Zhang
Journal:  Proteins       Date:  2011-10-04

7.  QSAR Studies on andrographolide derivatives as α-glucosidase inhibitors.

Authors:  Jun Xu; Sichao Huang; Haibin Luo; Guoji Li; Jiaolin Bao; Shaohui Cai; Yuqiang Wang
Journal:  Int J Mol Sci       Date:  2010-03-02       Impact factor: 5.923

8.  Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.

Authors:  Fang Bai; Yechun Xu; Jing Chen; Qiufeng Liu; Junfeng Gu; Xicheng Wang; Jianpeng Ma; Honglin Li; José N Onuchic; Hualiang Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

9.  Validating CHARMM parameters and exploring charge distribution rules in structure-based drug design.

Authors:  Jennifer L Knight; Charles L Brooks
Journal:  J Chem Theory Comput       Date:  2009       Impact factor: 6.006

10.  Structure-based substrate screening for an enzyme.

Authors:  Tao Xu; Lujia Zhang; Xuedong Wang; Dongzhi Wei; Tianbi Li
Journal:  BMC Bioinformatics       Date:  2009-08-21       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.